Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Understand which index funds are best for IRAs in 2024, with guidance on diversification, costs, and long-term retirement goals.
24,195 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
A proposed state ban on institutional buyers could change how Californians get loans for homes and how lenders price ...
Investors are buzzing about SpaceX's ambitious revenue target for 2030 and a bold rival coming from AI. This guide br...
KBR faced a two-sided story: a massive backlog that hints at strong future demand, and a prominent investor trimming ...
Abcellera's Q1 2026 earnings transcript provides key clues about the path to 2026. This guide breaks down revenue dri...
In many American cities, affordable homes and Section 8 properties are hard to find. This in-depth guide explains why...
Novo Nordisk stock faced renewed selling pressure this week as investors weighed trial results and government-driven ...
Capricor is at a crossroads as 2026 earnings season unfolds. This article breaks down what to look for in capricor (c...
Ford and GM are reshaping their business models by moving into energy-related assets like batteries, charging network...
Wedding venues can drain your budget fast. Here are three unusual tricks save money that real couples actually use—wi...
This guide breaks down where will palantir stock could land in five years. You’ll find scenarios, risks, and actionab...
A shift toward a more hawkish Fed path can reshape how we value large banks. This guide breaks down the math, expecta...